Our findings suggest that the RhoA/ROCK signaling pathway is important in the pathogenesis of CAD, so the inhibition of the activity of RhoA/ROCK-1 pathway would be beneficial in treating cardiovascular diseases. The gene discussed is RHOA; the disease is coronary artery disorder.